VERONICA POWELL: Open Payments
NPI 1811552623 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 10 payments from 7 companies in 2025. Trend: 2023 $86 · 2024 $61 · 2025 $266
Food & beverage: $155Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $15 |
| Corium, LLC | 2 | $9 |
Products named: CAPLYTA, Auvelity, ABILIFY ASIMTUFII, INGREZZA, Dyanavel XR, Azstarys.
Industry payments across WI — which companies pay providers there.
